Logo - springer
Slogan - springer

Life Sciences - Cell Biology | Journal of Cell Communication and Signaling - incl. option to publish open access (Editorial Board)

We’re working on a new version of this journal site - preview it now
Journal of Cell Communication and Signaling

Journal of Cell Communication and Signaling

Editor-in-Chief: Bernard Perbal

ISSN: 1873-9601 (print version)
ISSN: 1873-961X (electronic version)

Journal no. 12079

80,33 € Personal Rate e-only
Get Subscription

Online subscription, valid from January through December of current calendar year

Immediate access to this year's issues via SpringerLink

1 Volume(-s) with 4 issue(-s) per annual subscription

Automatic annual renewal

More information: >> FAQs // >> Policy

Bernard Perbal

GREDEG, Nice, France
President of the International CCN Society

Managing Editor
Andrew Leask, University of Western Ontario, Ontario, Canada

Section Editors
Pathology and Translational Research
Andrew Leask, University of Western Ontario, Ontario, Canada

Molecular Signaling
Satoshi Kubota, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

David Brigstock, Children's Research Institute, Columbus, USA

Bits and Bytes
Andrew Leask, University of Western Ontario, Ontario, Canada
Herman Yeger, The Hospital for Sick Children, Toronto, Canada

Administrative Assistant
Annick Perbal

Editorial Board
David Abraham, University College London, London, UK
K. Ravi Acharya, University of Bath, Bath, UK
Patrick Auberger, INSERM U1065, Nice, France
Sushanta Banerjee, University of Kansas Medical Center, Kansas City MO, USA
George Bou-Gharios, University of Liverpool, Liverpool, UK
Enrique Brandan, Pontificia Universidad Católica de Chile, Chile
Rolf Brekken, The University of Texas Southwestern Medical Center, Dallas TX, USA
Ernesto Canalis, St Francis Hospital and Medical Center, Hartford CT, USA
John Castellot, Tufts University, Boston MA, USA
Carlo Croce, Ohio State University Medical Center, Columbus OH, USA
Mick Dashwood, Royal Free Hospital, London, UK
Marc Diederich, Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Luxembourg
Gary Fisher, University of Michigan Mecial School, Ann Arbor MI, USA
Roel Goldschmeding, University Medical Center Utrecht, Utrecht, The Netherlands
Douglas Hamilton, University of Western Ontario, Ontario, Canada
Sandra Irvine, Queen's University Belfast, Belfast, Northern Ireland
Celina Kleer, University of Michigan, Ann Arbor MI, USA
Akira Kudo, Tokyo Institute of Technology, Tokyo, Japan
Paul Lasko, McGill University, Montreal QC, Canada
Lester Lau, University of Illinois, Chicago IL, USA
Jack Lawler, Beth Israel Deaconess Medical Center, Boston MA, USA
Zhiyong Lin, Case Western Reserve University, Cleveland OH, USA
Karen Lyons, UCLA, Los Angeles CA, USA
Kathryn E Meier, Washington State University, Spokane, WA, USA
Kohei Miyazono, University of Tokyo, Tokyo, Japan
Joanne E. Murphy-Ullrich, University of Alabama, Birmingham AL, USA
Christian Naus, University of British Columbia, Vancouver BC, Canada
Kunimasa Ohta, Kumamoto University, Kumamoto, Japan
Anie Philip, McGill University, Montreal QC, Canada
Lynne-Marie Postovit, University of Alberta, Edmonton AB, Canada
David D. Roberts, National Institutes of Health, Bethesda MD, USA
Katia Scotlandi, Istituti Ortopedici Rizzoli, Bologna, Italy
Peter Siegel, McGill University, Montreal QC, Canada
Ulf Smith, University of Gothenburg, Sweden
Masaharu Takigawa, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
Philip C. Trackman, Boston University, Boston MA, USA
Stephen Twigg, Royal Prince Alfred Hospital, Sydney, Australia
Toshimitsu Uede,  Hokkaido University, Sapporo, Japan
Ralf Weiskirchen, Aachen University Hospital, Germany
Denys Wheatley BioMedES Ltd., Aberdeenshire, UK

Advisory Board
Robert Baxter, University of Sydney, St Leonards, Australia
Edward Calabrese, University of Massachusetts, Amherst MA, USA
Meenhard Herlyn, The Wistar Institute, Philadelphia PA, USA
Piero Picci, Istituti Rizzoli, Bologna, Italy
Bernard Roizman, University of Chicago, Chicago IL, USA

For authors and editors

  • Journal Citation Reports®
    2018 Impact Factor
  • 3.691
  • Aims and Scope

    Aims and Scope


    The Journal of Cell Communication and Signaling provides a forum for fundamental and translational research.  In particular, it publishes papers discussing intercellular and intracellular signaling pathways that are particularly important to understand how cells interact with each other and with the surrounding environment, and how cellular behavior contributes to pathological states. JCCS encourages the submission of research manuscripts, timely reviews  and short commentaries discussing recent publications, key developments and controversies.

     Research manuscripts can be published under two different sections :.

    In the Pathology and Translational Research Section (Section Editor Andrew Leask) , manuscripts report original research dealing with celllular aspects of normal and pathological signaling and communication, with a particular interest in translational research.

    In the Molecular Signaling Section (Section Editor Satoshi Kubota) manuscripts report original signaling research performed at molecular levels with a particular interest in the functions of intracellular and membrane components involved in cell signaling.

     The Review Section (Section Editor David Brigstock) is a venue for publication of  review articles that summarize recent advances and discoveries, identify gaps and debates, and outline future directions in all aspects of cell signaling and communication. The Journal is particularly interested in focused and authoratative  mini-reviews that will allow the reader to gain a rapid understanding of the material presented.  Mini-reviews should not exceed 5000 words, excluding the abstract and bibliography. No more than 80 references should be cited.  Inclusion of figures to help summarize the major concepts is encouraged.  Authors are requested to contact the Section Editor with a proposed outline of their article before submission so that its suitability for publication in the journal can be assessed.

    The ‘At the Forefront of Unforeseen Science’ section (Section Editor Bernard Perbal publishes peer-reviewed articles reporting on groundbreaking discoveries that promise to have an impact on the future of mankind. The manuscripts should be written in the form of a concise analysis and review of exciting advances in any scientific field that will offer novel perspectives that could open new avenues for research and applications

    The Bits & Bytes section (Section Editors Andrew Leask and Herman Yeger) provides a forum for the rapid distribution of short commentaries on recent publications and news that are of interest to the scientific community. These commentaries also appear on the Web site of the International CCN Society (http://ccnsociety.com) as soon as they are accepted.

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for authors (pdf, 274 kB)
  • Instructions for Authors (new)

Alerts for this journal


Get the table of contents of every new issue published in Journal of Cell Communication and Signaling.